In cancer, the expression profiles of miRNAs are often dysregulated. Some miRNAs act as oncogenes (oncomiRs) by downregulating tumor suppressor genes, while others function as tumor suppressors by inhibiting oncogenes. Their dysregulation can contribute to various hallmarks of cancer, such as sustained proliferative signaling, evading growth suppressors, resisting cell death, and enabling replicative immortality.
